{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:54:53Z","timestamp":1790297693178,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002003"],"award-info":[{"award-number":["UL1TR002003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajpc.2025.101002","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:50:52Z","timestamp":1746114652000},"page":"101002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cardiovascular disease risk factors in newly diagnosed rheumatoid arthritis: A retrospective cohort study"],"prefix":"10.1016","volume":"22","author":[{"given":"Avi G.","family":"Aronov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-5792","authenticated-orcid":false,"given":"Noreen T.","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10354","key":"10.1016\/j.ajpc.2025.101002_bib0001","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101002_bib0002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101002_bib0003","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"American Heart Journal"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101002_bib0004","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"27","key":"10.1016\/j.ajpc.2025.101002_bib0005","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101002_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2013-204987","article-title":"Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration","volume":"75","author":"Navarro-Mill\u00e1n","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101002_bib0007","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101002_bib0008","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.39165","article-title":"Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients","volume":"67","author":"Liao","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101002_bib0009","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1742-1241.2009.02220.x","article-title":"The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better: Lipid pattern in rheumatoid arthritis","volume":"64","author":"Peters","year":"2010","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.ajpc.2025.101002_bib0010","unstructured":"Minority Serving Institution List.; 2022. https:\/\/orise.orau.gov\/msipp\/documents\/approved-msi-school-list.pdf."},{"key":"10.1016\/j.ajpc.2025.101002_bib0011","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101002_bib0012","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101002_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","article-title":"Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives","volume":"70","author":"Kitas","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101002_bib0014","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3899\/jrheum.131042","article-title":"C-reactive protein versus erythrocyte sedimentation rate in estimating the 28-joint disease activity score","volume":"40","author":"Gaujoux-Viala","year":"2013","journal-title":"J Rheumatol"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101002_bib0015","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.3390\/ijms21249505","article-title":"The lipid paradox as a metabolic checkpoint and its therapeutic significance in ameliorating the associated cardiovascular risks in rheumatoid arthritis patients","volume":"21","author":"Behl","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101002_bib0016","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the american heart association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101002_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117952","article-title":"The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Baghdadi","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101002_bib0018","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2008.095596","article-title":"Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis","volume":"68","author":"Stavropoulos-Kalinoglou","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"10.1016\/j.ajpc.2025.101002_bib0019","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","article-title":"Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation","volume":"165","author":"Escalante","year":"2005","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101002_bib0020","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101002_bib0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amepre.2021.08.019","article-title":"Smoking and risk of premature atherosclerotic cardiovascular disease","volume":"62","author":"Rana","year":"2022","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajpc.2025.101002_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100380","article-title":"Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis","volume":"12","author":"Aronov","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101002_bib0023","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101002_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14745","article-title":"Demographic characteristics of participants in rheumatoid arthritis randomized clinical trials","volume":"2","author":"Strait","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101002_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004546","article-title":"Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis","volume":"10","author":"Karpouzas","year":"2024","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101002_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32834ff2fd","article-title":"Risk factors for cardiovascular disease in rheumatoid arthritis","volume":"24","author":"Gabriel","year":"2012","journal-title":"Current Opinion in Rheumatology"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:38:03Z","timestamp":1751989083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S2666667725000777"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101002","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease risk factors in newly diagnosed rheumatoid arthritis: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101002"}}